Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1995-04-10
1999-10-05
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
514 12, 530304, 530325, 4241851, A61K 3900, A61K 3938, A61K 3800, C07K 500
Patent
active
059619775
ABSTRACT:
The present invention provides a method of treating or preventing the clinical manifestation of an autoimmune disease having the symptoms of uveoretinitis in a mammal in need of such treatment comprising orally administering to said mammal an effective amount of an autoantigen, e.g., S antigen (S-Ag), and/or biologically active fragments, or analogs thereof specific for uveoretinitis.
Also provided is a pharmaceutical formulation useful for treating or preventing uveoretinitis in mammals comprising an effective amount of one or more of the foregoing autoantigen, fragments or analogs.
REFERENCES:
Faure, Jean-Pierre et al., Cellular and humoral reactions to retinal antigen; specific suppression of experimental uveoretinitis, Proceeding 'Immunology of the eye; Workshop: II', Eds. Helmsen, R.J., Suran, A., Gery, I. and Nussenblatt, R.B., Sp. Supp. Immunology Abstracts, 1981, pp. 33-48, 1981.
Ben-Nun, A. et al., "The Rapid Isolation of Clonable Antigen-Specific T Lymphocyte Lines Capable of Mediating Autoimmune Encephalomyelitis," Eur. J. Immunol 11:195-199 (1981).
Bitar, D.M. and C.C. Whitacre, "Suppression of Experimental Autoimmune Encephalomyelitis by the Oral Administration of Myelin Basic Protein," Cell Immunol. 112:364-370 (1988).
Caspi, R.R. et al., "T Cell Lines Mediating Experimental Autoimmune Uveoretinitis (EAU) in the Rat," J. Immunol. 136:928-933 (1986).
De Kozak, Y. et al., "Prevention of Experimental Autoimmune Uveoretinitis by Active Immunization with Autoantigen-specific Monoclonal Antibodies," Eur. J. Immunol. 17:541-547 (1987).
De Kozak, Y. et al., Annales D'Immunologie, "Suppression Et Traitement De L'uveo-Retinite Autoimmune Experimentale Par Injections D'Extraits De Retine," 129C 73-88 (1978).
Deibler, G.E. et al., "Large Scale Preparation of Myelin Basic Protein from Central Nervous Tissue of Several Mammalian Species," Prep. Biochem. 2:139-165 (1972).
Donoso, L.A. et al., "Human IRBP:Characterization of Uveitopathogenic Sites," Curr. Eye Res. 7:1087-1095 (1988).
Dorey, C. et al., "A Simple and Rapid Method for Isolation of Retinal S Antigen," Ophthalmic Res. 14:249-255 (1982).
Douglas, K. and Prince, C., "Eating Away at Disease," New Science pp. 36-40 (1995).
Gery, I. et al., "Retinal Specific Antigens and Immunopathogenic Processes They Provoke," N. Osborne and J. Chader (eds): Progress in Retinal Research, Oxford, Pergamon Press, vol. 5, pp. 75-109 (1986).
Gregerson, D.S. et al., "S-Antigen Specific Rat T Cell Lines Mediate EAU and EAP," Modern Trends in Immunology and Immunopathology of the Eye, Secchi, A.G., and I.A. Fregona (eds), Masson, Milan, pp. 20-25 (1989).
Gregerson, D.S. et al., "S-Antigen-Specific Rat T Cell Lines Recognize Peptide Fragments of S-Antigen and Mediate Experimental Autoimmune Uveoretinitis and Pinealitis," The Journal of Immunology 136:2875-2882 (1986).
Gregerson, D.S. et al., "Selection of Antibody Epitopes in an Immunopathogenic Neural Autoantigen," Journal of Neuroimmunology 24:191-206 (1989).
Gregerson, D.S. et al., "Identification of T Cell Recognition Sites in S-Antigen: Dissociation of Proliferative and Pathogenic Sites," Cellular Immunology 123:427-440 (1989).
Gregerson, D.S. et al., "Characterization of Immunologically Active Cyanogen Bromide Peptide Fragments of Bovine and Human Retinal S-Antigen," Exp. Eye Res. 43:803-818 (1986).
Gregerson, D.S. et al., "Preparation, Isolation, and Immunochemical Studies of the Cyanogen Bromide Peptides from a Retinal Photoreceptor Cell Autoantigen, S-Antigen," The Journal of Immunology 133:843-848 (1984).
Hafler, D.A., "Oligoclonal T Lymphocytes in the Cerebrospinal Fluid of Patients with Multiple Sclerosis," et al., J. Exp. Med. 167:1313-1322 (1988).
Higgins, P.J. and H.L. Weiner,"Suppression of Experimental Autoimmune Encephalomyelitis by Oral Administration of Myelin Basic Protein and Its Fragments," J. Immunol. 140:440-445 (1988).
Hirose, S. et al., "Lymphocyte Responses to Retinal-Specific Antigens in Uveitis Patients and Healthy Subjects," Current Eye Research 7:393-402 (1988).
Hirtenstein, A., "A Convenient Synthesis of Labelled Rhodopsin and Studies on its Active Site," Biochem. J., 119:359-366 (1970).
Lider, et al., "Suppression of Experimental Autoimmune Encephalomyelitis by Oral Administration of Myelin Basic Protein," J. Immunol. 142:748-752 (1989).
Mokhtarian, "Adoptive Transfer of Myelin Basic Protein-Sensitized T Cells Produces Chronic Relapsing Demyelinating Disease in Mice," Nature 309:356-358 (1984).
Nussenblatt, R.B. and A.G. Palestine, "Cyclosporine:Immunology, Pharmacology and Therapeutic Uses," Surv. Ophthalmol. 31:159-169 (1986).
Nussenblatt, R.B. et al., "Cyclosporin A Inhibition of Experimental Autoimmune Uveitis in Lewis Rats," J. Clin. Invest. 67:1228-1231 (1981).
Nussenblatt, R.B. et al., "Cyclosporin A Therapy in the Treatment of Intraocular Inflammatory Disease Resistant to Systemic Corticosteroids and Cytotoxic Agents," Am. J. Ophthalmol. 96:275-282 (1983).
Nussenblatt, R.B. et al., "Local Cyclosporine Therapy for Experimental Autoimmune Uveitis in Rats," Arch. Ophthalmol. 103:1559-1562 (1985).
Nussenblatt, R.B. et al., "Cellular Immune Responsiveness of Uveitis Patients to Retinal S-Antigen," Am. J. Ophthalmol. 89:173-179 (1980).
Nussenblatt, R.B. et al., "Birdshot Retinochoroidopathy Associated with HLA-A29 Antigen and Immune Responsiveness to Retinal S-Antigen," Am. J. Ophthalmol. 94:147-158 (1982).
Nussenblatt, R.B. et al., "Inhibition of S-Antigen Induced Experimental Autoimmune Uveoretinitis by Oral Induction of Tolerance with S-Antigen," J. of Immunol. 144:1689-1695.
Nussenblatt, R.B. et al., "Treatment of Intraocular Inflammatory Disease with Cyclosporin A," The Lancet pp. 235-238, Jul. 30, 1983.
Oppenheim, J.J. et al., "Lymphocyte Transformations: Utilization of Automatic Harvesters," In Vitro Methods and Tumor Immunity, Bloom B.R., et al, Eds, Acad. Press, NY, pp. 573-585 (1976).
Redmond, T.M. et al., "Isolation and Characterization of Monkey Interphotoreceptor Retinoid-Binding Protein, a Unique Extracellular Matrix Component of the Retina," Biochem. 24:787-793 (1985).
Richman, L.K. et al., "Enterically Induced Immunologic Tolerance," The Journal of Immunology, 121:2429-2434 (1978).
Sanui, H. et al., "Identification of an Immunodominant and Highly Immunopathogenic Determinant in the Retinal Interphotoreceptor Retinoid-Binding Protein (IRBP)," J. Exp. Med. 169:1947-1960 (1989).
Sanui, H. et al., Chem. Abstracts 109:168702y, p. 572 (1988).
Sanui, H. et al., Chem. Abstracts 111:55593m, p. 579 (1989).
Sanui, H. et al., "Synthetic Peptides from IRBP Induce EAU and EAP in Lewis Rats," Curr. Eye Research 7:727-735 (1988).
Shields et al., "The Purification and Amino Acid Composition of Bovine Rhodopsin," Biochem. Biophys. Acta 147:238-251 (1967).
Shinohara, T. et al., "S-Antigen: Structure, Function and Experimental Autoimmune Uveitis (EAU)," Progress in Retinal Research, Osborne and Chader Eds. Pergamon Press, pp. 51-66.
Singh, V.K. et al., "Identification of a Uveitopathogenic and Lymphocyte Proliferation Site in Bovine S-Antigen," Cellular Immunology 115:413-419 (1988).
Wacker, W.B. et al., "Experimental Allergic Uveitis. Isolation, Characterization, and Localization of A Soluble Uveitopathogenic Antigen from Bovine Retina," The Journal of Immunology 119:1949-1958 (1977).
Wald, B., "The Synthesis of Rhodopsin from Retinene," Proc. Natl. Acad. Sci. USA 36:84-92 (1950).
Hafler David Allen
Nussenblatt Robert B.
Palestine Alan G.
Weiner Howard L.
Autoimmune Inc.
Smith Lynette F.
The United States of America as represented by the Department of
LandOfFree
Method of treating or preventing autoimmune uveoretinitis in mam does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating or preventing autoimmune uveoretinitis in mam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating or preventing autoimmune uveoretinitis in mam will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168390